IL86862A - Pharmaceutical compositions for reducing the level of circulating immune complexes in vivo, containing mismatched double-stranded rna - Google Patents

Pharmaceutical compositions for reducing the level of circulating immune complexes in vivo, containing mismatched double-stranded rna

Info

Publication number
IL86862A
IL86862A IL86862A IL8686288A IL86862A IL 86862 A IL86862 A IL 86862A IL 86862 A IL86862 A IL 86862A IL 8686288 A IL8686288 A IL 8686288A IL 86862 A IL86862 A IL 86862A
Authority
IL
Israel
Prior art keywords
stranded rna
vivo
immune complexes
reducing
level
Prior art date
Application number
IL86862A
Other languages
English (en)
Other versions
IL86862A0 (en
Original Assignee
Hem Res Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hem Res Inc filed Critical Hem Res Inc
Publication of IL86862A0 publication Critical patent/IL86862A0/xx
Publication of IL86862A publication Critical patent/IL86862A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Pain & Pain Management (AREA)
  • Oncology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Steroid Compounds (AREA)
IL86862A 1987-07-17 1988-06-26 Pharmaceutical compositions for reducing the level of circulating immune complexes in vivo, containing mismatched double-stranded rna IL86862A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7461687A 1987-07-17 1987-07-17
US12457787A 1987-11-24 1987-11-24

Publications (2)

Publication Number Publication Date
IL86862A0 IL86862A0 (en) 1988-11-30
IL86862A true IL86862A (en) 1993-05-13

Family

ID=26755855

Family Applications (1)

Application Number Title Priority Date Filing Date
IL86862A IL86862A (en) 1987-07-17 1988-06-26 Pharmaceutical compositions for reducing the level of circulating immune complexes in vivo, containing mismatched double-stranded rna

Country Status (18)

Country Link
EP (1) EP0300680B1 (fr)
JP (1) JP2601520B2 (fr)
KR (1) KR0131880B1 (fr)
CN (1) CN1035050A (fr)
AT (1) ATE142500T1 (fr)
AU (2) AU1820588A (fr)
CA (1) CA1326999C (fr)
DE (1) DE3855527T2 (fr)
DK (1) DK399288A (fr)
ES (1) ES2093607T3 (fr)
FI (1) FI883352A7 (fr)
HU (1) HUT47432A (fr)
IE (1) IE76914B1 (fr)
IL (1) IL86862A (fr)
NO (1) NO175023C (fr)
NZ (1) NZ225310A (fr)
OA (1) OA08890A (fr)
PT (1) PT87996B (fr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4963532A (en) * 1987-11-25 1990-10-16 Hem Research, Inc. dsRNA-based prevention of viral escape
EP0473576A4 (en) * 1989-05-19 1993-03-10 Hem Research, Inc. Short therapeutic dsrna of defined structure
DE69029738T2 (de) * 1989-10-11 1997-08-14 Hem Pharma Corp Schutz gegen schock infolge einer schädigung durch doppelsträngige rna's
ZA908037B (en) * 1989-10-11 1991-09-25 Hem Res Inc Protection from shock subsequent to injury by double-standed rnas
US5132292A (en) * 1990-05-25 1992-07-21 Hem Research, Inc. Treatment of viral hepatitis
GB9108085D0 (en) * 1991-04-16 1991-06-05 Scras Complexes of polyadenylic acid with polyuridylic acid
WO1993001717A1 (fr) * 1991-07-16 1993-02-04 Hem Pharmaceuticals Corp. Modulation et diagnostic du dysfonctionnement des cytokines
FR2768344B1 (fr) * 1997-08-26 2001-02-16 Scras Produit comprenant au moins un arn double brin en association avec au moins un agent anti-viral pour une utilisation therapeutique dans le traitement d'une maladie virale
FR2766715B1 (fr) * 1997-08-04 2001-02-16 Scras Produit comprenant au moins de l'arn double brin en association avec au moins un agent anti-viral pour une utilisation therapeutique simultanee, separee ou etalee dans le temps, dans le traitement d'une maladie virale
TW589189B (en) 1997-08-04 2004-06-01 Scras Kit containing at least one double-stranded RNA combined with at least one anti-viral agent for therapeutic use in the treatment of a viral disease, notably of viral hepatitis
FR2768345B1 (fr) * 1997-09-17 2001-05-04 Scras Produit comprenant au moins un arn double brin en association avec au moins un agent anti-viral pour une utilisation therapeutique dans le traitement d'une maladie virale, notamment d'une hepatite virale
US6506559B1 (en) 1997-12-23 2003-01-14 Carnegie Institute Of Washington Genetic inhibition by double-stranded RNA
BRPI9908967B1 (pt) 1998-03-20 2017-05-30 Benitec Australia Ltd processos para reprimir, retardar ou de outro modo reduzir a expressão de um gene alvo em uma célula de planta
AUPP249298A0 (en) 1998-03-20 1998-04-23 Ag-Gene Australia Limited Synthetic genes and genetic constructs comprising same I
WO2000044914A1 (fr) 1999-01-28 2000-08-03 Medical College Of Georgia Research Institute, Inc. Composition et methode destinees a l'attenuation in vivo et in vitro de l'expression genique utilisant de l'arn double brin
US6423885B1 (en) 1999-08-13 2002-07-23 Commonwealth Scientific And Industrial Research Organization (Csiro) Methods for obtaining modified phenotypes in plant cells
CA2369944A1 (fr) 2001-01-31 2002-07-31 Nucleonics Inc. Utilisation de l'inhibition genetique post-transcriptionnelle pour identifier les sequences d'acides nucleiques qui modulent la fonction d'une cellule
EP2351576A1 (fr) * 2004-12-29 2011-08-03 Mannkind Corporation Procédés pour déclencher, maintenir et manipuler les réponses immunologiques par l'administration ciblée de modificateurs de réponse biologique dans des organes lymphoïdes
KR102317281B1 (ko) * 2015-11-17 2021-10-25 하이라이트 테라퓨틱스 에스.엘. 이본쇄 폴리리보뉴클레오타이드 및 폴리알킬렌이민의 복합체를 포함하는 입자를 포함하는 신규 약제학적 조성물
CN105434341B (zh) * 2015-12-22 2018-07-10 肇庆大华农生物药品有限公司 一种兽用聚腺尿苷酸注射液及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4024222A (en) * 1973-10-30 1977-05-17 The Johns Hopkins University Nucleic acid complexes
US4140761A (en) * 1977-04-11 1979-02-20 The United States Of America As Represented By The Department Of Health, Education & Welfare Modification of hepatitis B virus infection in chronic carriers of hepatitis B surface antigen
DE3380200D1 (en) * 1982-09-16 1989-08-24 William Alvin Carter Anti-proliferative action of dsnras on tumor cells
CA1326450C (fr) * 1985-08-26 1994-01-25 William A. Carter Modulation des manifestations associees au virus du sida au moyen d'arn a double brin

Also Published As

Publication number Publication date
EP0300680B1 (fr) 1996-09-11
NO175023C (no) 1994-08-17
PT87996A (pt) 1989-06-30
HUT47432A (en) 1989-03-28
DE3855527T2 (de) 1997-04-03
JPS6490126A (en) 1989-04-06
OA08890A (en) 1989-10-31
CN1035050A (zh) 1989-08-30
AU1761195A (en) 1995-06-29
KR0131880B1 (ko) 1998-04-17
AU1820588A (en) 1989-01-19
NO882853L (no) 1989-01-18
IE76914B1 (en) 1997-11-05
FI883352A0 (fi) 1988-07-14
DK399288D0 (da) 1988-07-15
CA1326999C (fr) 1994-02-15
FI883352L (fi) 1989-01-18
JP2601520B2 (ja) 1997-04-16
KR890001580A (ko) 1989-03-27
FI883352A7 (fi) 1989-01-18
NZ225310A (en) 1991-05-28
EP0300680A2 (fr) 1989-01-25
IL86862A0 (en) 1988-11-30
EP0300680A3 (fr) 1991-06-19
DK399288A (da) 1989-01-18
PT87996B (pt) 1995-03-31
ATE142500T1 (de) 1996-09-15
DE3855527D1 (de) 1996-10-17
ES2093607T3 (es) 1997-01-01
NO882853D0 (no) 1988-06-28
IE881894L (en) 1989-01-17
NO175023B (no) 1994-05-09

Similar Documents

Publication Publication Date Title
OA08890A (en) Double-stranded RNA correction of abnormalitie in circulating immune complexes and monocyte function.
PH31649A (en) Process for the production of TGF beta.
PT707487E (pt) Metodos e composicoes farmaceuticas uteis no tratamento de disturbios neurologicos
EP0306347A3 (en) Diagnosis and treatment of double-stranded rna deficiency states
PT86346A (en) Method of treatment by means of the 3:-deoxitimidinene-2:(3:deoxi-2:3:-didesidrotimidine) administration to animals of hot blood infected with retrovirus
EP0344880A3 (en) Pharmaceutical compositions with anti-cancer activity and method for the treatment of cancer
IT8322855A0 (it) Composizione farmaceutica per la cura delle arteriopatie periferiche.
EP0455448A3 (en) Treatment of pancreatic disease with 15-keto-prostaglandin compounds
IE890580L (en) Therapeutic agent for the prevention of intraventricular hemorrhage in premature infants
GR3018674T3 (en) Treatment of hepatobiliary disease with 15-keto-prostaglandin compounds
FR2707638B1 (fr) Nouveaux dérivés d'amino-acides, leurs procédés de préparation et leur application thérapeutique.
OA09509A (en) Treatment of leukocyte dysfunction with GM-CSF
DE69007065D1 (de) Verwendung von Diadenosin-5',5'''-p1,p4-tetraphosphat zur Herstellung eines Arzneimittels zur Behandlung von Herzkrankheiten.
GR3026105T3 (en) Treatment of cardiac dysfunction with 15-keto-prostaglandin compounds
DE59304087D1 (de) Placentaextrakt und Verfahren zu seiner Herstellung
Hassenfeld et al. A study of the right to refuse treatment.
EP0227356A3 (en) The use of depogen in the treatment of restricted blood circulation
ZA873928B (en) Topical methotrexate preparation for the treatment of hyperproliferative epithelial disease
EP0292397A3 (en) Extracorporeal blood circulating apparatus
Rosenberg Psychoactive behavior.
Padovani et al. Clinical efficacy and tolerance of ceftazidime as sole antibiotic in neonatal bacterial infections.
IT1238210B (it) Esteri del cefamandolo nafato, procedimento per la loro preparazione erelative composizioni farmaceutiche.
OA09766A (en) "Treatment of anxiety in benzodiazepine-withdrawn patients".
EP0292398A3 (en) Extracorporeal blood circulating apparatus
EP0292396A3 (en) Extracorporeal blood circulating apparatus

Legal Events

Date Code Title Description
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees